An FDA approval put Ki-67 scoring — which may predict tumor growth — in the spotlight, but what that means long term to patients depends on who you ask. The speed at which cancer cells grow can be an ...
A high omega-3, low omega-6 diet with fish oil reduced the Ki-67 index by 15% in prostate cancer patients on active surveillance. The control group showed a 24% increase in the Ki-67 index, ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early ...
(RTTNews) - Quest Diagnostics (DGX), on Monday, said it has decided to introduce clinical laboratory testing using Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic. The ...
(RTTNews) - Agilent Technologies Inc. (A) Wednesday said that the U.S. Food and Drug Administration approved its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) as an aid in identifying patients with early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback